Tyra Biosciences, Inc.
TYRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $25,469 | $24,309 | $24,964 | $22,180 |
| G&A Expenses | $7,475 | $7,143 | $6,886 | $7,564 |
| SG&A Expenses | $7,475 | $7,143 | $6,886 | $7,564 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $32,944 | $31,452 | $31,850 | $29,744 |
| Operating Income | -$32,944 | -$31,452 | -$31,850 | -$29,744 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3,076 | $3,354 | $3,703 | $4,173 |
| Pre-Tax Income | -$29,868 | -$28,098 | -$28,147 | -$25,571 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$29,868 | -$28,098 | -$28,147 | -$25,571 |
| % Margin | – | – | – | – |
| EPS | -0.5 | -0.47 | -0.47 | -0.43 |
| % Growth | -6.4% | 0% | -9.3% | – |
| EPS Diluted | -0.5 | -0.47 | -0.47 | -0.43 |
| Weighted Avg Shares Out | 59,671 | 59,551 | 59,337 | 58,874 |
| Weighted Avg Shares Out Dil | 59,671 | 59,551 | 59,337 | 58,874 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $3,354 | $3,703 | $4,173 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $131 | $140 | $143 | $144 |
| EBITDA | -$29,737 | -$31,312 | -$31,707 | -$29,600 |
| % Margin | – | – | – | – |